Literature DB >> 19836360

Reaction of human albumin with aspirin in vitro: mass spectrometric identification of acetylated lysines 199, 402, 519, and 545.

Mariya S Liyasova1, Lawrence M Schopfer, Oksana Lockridge.   

Abstract

The aspirin esterase activity of human plasma is due to butyrylcholinesterase and albumin. Our goal was to identify the amino acid residues involved in the aspirin esterase activity of albumin. Fatty acid-free human albumin and human plasma were treated with aspirin for 5 min-24 h. Acetylated residues were identified by LC/MS/MS and MALDI-TOF/TOF mass spectrometry of tryptic peptides. Treatment with 0.3 mM aspirin resulted in acetylation of Lys-199, Lys-402, Lys-519, and Lys-545. Treatment with 20 mM aspirin resulted in acetylation of 26 lysines. There was no acetylation of Tyr-411, under any conditions. Acetylated lysine was stable for at least 21 days at pH 7.4, 37 degrees C. Albumin acetylated by aspirin had reduced esterase activity with beta-naphthyl acetate as shown on gels stained for esterase activity. It was concluded that the aspirin esterase activity of albumin is a pseudo-esterase activity in which aspirin stably acetylates lysines and releases salicylate. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19836360      PMCID: PMC2812595          DOI: 10.1016/j.bcp.2009.10.007

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  28 in total

1.  Probability-based protein identification by searching sequence databases using mass spectrometry data.

Authors:  D N Perkins; D J Pappin; D M Creasy; J S Cottrell
Journal:  Electrophoresis       Date:  1999-12       Impact factor: 3.535

2.  Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage.

Authors:  Wanda M Bodnar; R Kevin Blackburn; Jo M Krise; M Arthur Moseley
Journal:  J Am Soc Mass Spectrom       Date:  2003-09       Impact factor: 3.109

3.  Optical studies of drug-protein complexes. V. The interaction of phenylbutazone, flufenamic acid, and dicoumarol with acetylsalicylic acid-treated human serum albumin.

Authors:  C F Chignell; D K Starkweather
Journal:  Mol Pharmacol       Date:  1971-05       Impact factor: 4.436

4.  Hydrolysis of salicylsalicylic acid in human blood and plasma: a comparison with acetylsalicylic acid.

Authors:  L Harthon; M Hedström
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

5.  Molecular dynamics study of the IIA binding site in human serum albumin: influence of the protonation state of Lys195 and Lys199.

Authors:  N Díaz; D Suárez; T L Sordo; K M Merz
Journal:  J Med Chem       Date:  2001-01-18       Impact factor: 7.446

6.  An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose.

Authors:  P I Dargan; C I Wallace; A L Jones
Journal:  Emerg Med J       Date:  2002-05       Impact factor: 2.740

7.  Pseudo-esterase activity of human albumin: slow turnover on tyrosine 411 and stable acetylation of 82 residues including 59 lysines.

Authors:  Oksana Lockridge; Weihua Xue; Andrea Gaydess; Hasmik Grigoryan; Shi-Jian Ding; Lawrence M Schopfer; Steven H Hinrichs; Patrick Masson
Journal:  J Biol Chem       Date:  2008-06-24       Impact factor: 5.157

8.  Structural changes in human serum albumin induced by ingestion of acetylsalicylic acid.

Authors:  D Hawkins; R N Pinckard; I P Crawford; R S Farr
Journal:  J Clin Invest       Date:  1969-03       Impact factor: 14.808

9.  Acetylation of human serum albumin by acetylsalicylic acid.

Authors:  D Hawkins; R N Pinckard; R S Farr
Journal:  Science       Date:  1968-05-17       Impact factor: 47.728

10.  Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates.

Authors:  Yuji Sakurai; Shen-Feng Ma; Hiroshi Watanabe; Noriyuki Yamaotsu; Shuichi Hirono; Yukihisa Kurono; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

View more
  17 in total

Review 1.  Drug Concentration Asymmetry in Tissues and Plasma for Small Molecule-Related Therapeutic Modalities.

Authors:  Donglu Zhang; Cornelis E C A Hop; Gabriela Patilea-Vrana; Gautham Gampa; Herana Kamal Seneviratne; Jashvant D Unadkat; Jane R Kenny; Karthik Nagapudi; Li Di; Lian Zhou; Mark Zak; Matthew R Wright; Namandjé N Bumpus; Richard Zang; Xingrong Liu; Yurong Lai; S Cyrus Khojasteh
Journal:  Drug Metab Dispos       Date:  2019-07-02       Impact factor: 3.922

2.  Using lysine adducts of human serum albumin to investigate the disposition of exogenous formaldehyde in human blood.

Authors:  Luca G Regazzoni; Hasmik Grigoryan; Zhiying Ji; Xi Chen; Sarah I Daniels; Deyin Huang; Sylvia Sanchez; Naijun Tang; Fenna C M Sillé; Anthony T Iavarone; Evan R Williams; Luoping Zhang; Stephen M Rappaport
Journal:  Toxicol Lett       Date:  2017-01-16       Impact factor: 4.372

3.  Tandem mass spectral libraries of peptides in digests of individual proteins: Human Serum Albumin (HSA).

Authors:  Qian Dong; Xinjian Yan; Lisa E Kilpatrick; Yuxue Liang; Yuri A Mirokhin; Jeri S Roth; Paul A Rudnick; Stephen E Stein
Journal:  Mol Cell Proteomics       Date:  2014-06-02       Impact factor: 5.911

4.  SNX3-dependent regulation of epidermal growth factor receptor (EGFR) trafficking and degradation by aspirin in epidermoid carcinoma (A-431) cells.

Authors:  Kher Hsin Chiow; Yingrou Tan; Rong Yuan Chua; Dachuan Huang; Mah Lee Mary Ng; Federico Torta; Markus R Wenk; Siew Heng Wong
Journal:  Cell Mol Life Sci       Date:  2011-12-11       Impact factor: 9.261

5.  Cresyl saligenin phosphate makes multiple adducts on free histidine, but does not form an adduct on histidine 438 of human butyrylcholinesterase.

Authors:  Mariya S Liyasova; Lawrence M Schopfer; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2012-08-08       Impact factor: 5.192

6.  Aspirin inhibits TGFβ2-induced epithelial to mesenchymal transition of lens epithelial cells: selective acetylation of K56 and K122 in histone H3.

Authors:  Mi-Hyun Nam; Andrew J O Smith; Mina B Pantcheva; Ko Uoon Park; Joseph A Brzezinski; James J Galligan; Kristofer Fritz; I Michael Wormstone; Ram H Nagaraj
Journal:  Biochem J       Date:  2020-01-17       Impact factor: 3.857

7.  Structural mechanism of ring-opening reaction of glucose by human serum albumin.

Authors:  Yu Wang; Haiyang Yu; Xiaoli Shi; Zhipu Luo; Donghai Lin; Mingdong Huang
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

8.  Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes.

Authors:  Uta Greifenhagen; Andrej Frolov; Matthias Blüher; Ralf Hoffmann
Journal:  J Biol Chem       Date:  2016-03-01       Impact factor: 5.157

9.  Quantitative Profiling of Post-translational Modifications by Immunoaffinity Enrichment and LC-MS/MS in Cancer Serum without Immunodepletion.

Authors:  Hongbo Gu; Jian Min Ren; Xiaoying Jia; Tyler Levy; Klarisa Rikova; Vicky Yang; Kimberly A Lee; Matthew P Stokes; Jeffrey C Silva
Journal:  Mol Cell Proteomics       Date:  2015-12-03       Impact factor: 5.911

10.  Prediction of Human Pharmacokinetic Profiles of the Antituberculosis Drug Delamanid from Nonclinical Data: Potential Therapeutic Value against Extrapulmonary Tuberculosis.

Authors:  Masakazu Shibata; Masatoshi Masuda; Katsunori Sasahara; Hiroyuki Sasabe; Tomohiro Sasaki; Seongryul Kim; Kenji Takeuchi; Ken Umehara; Eiji Kashiyama
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.